Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

We all react to environmental cues that tell us it’s time to eat, like the scent of fries wafting through the air. These cues ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...

Novo's Ozempic is approved by the U.S. Food and Drug Administration ... This year, the FDA approved the company's Alzheimer's ...

New Alzheimer's disease drugs, a world-first skin cancer vaccine, and personalised health apps that change the way we track ...

Euronews Health looks at some of this year’s top medical advances and the key areas of health that were the most solicited ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

MILLIONAIRE ‘biohacker’ Bryan Johnson has embarked on several wacky schemes in a bid to turn back the clock. They range from infusing his son’s plasma into his blood to injecting a ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

From GLP-1RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read outs of 2024.